INTRODUCTION
. SGLT (sodium glucose cotransporter protein) family members. 1A and 1B: The common names, system names, and human reference sequence numbers of the 12 SGLT family members are listed. The putative substrates of the transporters and the chromosomal locations of the transporter genes are given in the tables. 1C: Percentage of protein sequence identity among SGLT family members as determined with VectorNTI AlignX software.
There are more than 200 SGLT family members, including 12 human orthologs. 5 Based on sequence homology, these 12 SGLT family members can be divided into two subfamilies, as shown in Table 1 . SGLT1, SGLT2, sodiumdependent amino acid transporter (SAAT1; also known as SGLT3), sodium myo-inositol cotransporter (SMIT), SGLT4, SGLT5, and SGLT6
belong to one subfamily, sharing between 45%
and 70% protein sequence identity amongst themselves. Most of the members of this subfamily transport or bind sugar molecules.
The five other solute carrier family 5A (SLC5A)
family members Na+/I-symporter (NIS), sodium-dependent multivitamin transporter (SMVT), choline transporter (CHT), apical iodide transporter/sodium monocarboxylate cotransporter 1 (AIT/SMCT1), and SMCT2 form another subfamily. They share between 40%
and 50% protein sequence identity amongst themselves; members of this latter subfamily are involved in the cotransport of sodium with other physiologically important molecules such as iodide, ascorbate, biotin, pantothenate, lipoate, choline, and monocarboxylates such as lactate. 5 Since only 18% to 20% protein sequence identity exists between the two subfamilies, the focus of our studies was the sugar-binding class of SGLT cotransporters most closely related to SGLT2 (Table 1) .
The first sugar-binding SGLT sequence to be cloned, by Wright and colleagues, was the highaffinity sodium-glucose cotransporter SGLT1, which was found to be expressed in the small intestinal mucosa 6 and associated with glucose and galactose transport at that site. SGLT1 was later found to be expressed in many tissues across the body, 7 and mutations in SGLT1 were associated with the human genetic syndrome glucose-galactose malabsorption. 8 SGLT2 was cloned subsequently, and was characterized as a low-affinity sodium-glucose cotransporter expressed in the renal early proximal tubule. The chromosomal coordinates and exon locations of the amplicons are determined by alignment of the amplicon sequences against human genome GRCh37 Assembly (hg19) on the UCSC Genome Browser.
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Tissue expression profiling of the seven SGLT family members reveals distinct patterns of tissue expression, summarized below.
The Kidney-Specific and Kidney-Abundant Figure 1A presents the results evaluating the expression of SGLT2 from a subset of the 72 tissues profiled (data from all the tissues are available in the Appendix, Additional Figure   S1 ) with a primer/probe set (SGLT2-e6 ,7) designed to span the boundaries of exons 6 and 7 of SGLT2, as noted in Table 2 (Table S2) , possibly due to greater primer/probe set efficiency; however, even in this case, kidney expression was 100-fold higher than in the next highest tissue observed (the ileum).
SGLT Family Members
In addition, the primer/probe combination (SGLT2-e13), located in exon 13 close to the 3' end of the SGLT2 gene and identical to the one used by Zhou et al., 22 shows that the SGLT2 gene is highly specifically expressed in the kidney ( Figure 1B , Figure S5 , and Table S2 ), unlike the result previously reported by these investigators.
We observed that this primer/probe set essentially mirrors the data obtained with the primer/probe set spanning the junction of exons 6 and 7, as well as primer/probe sets spanning the exons 1-2, 4-5, and 9-10. We note that the primer/probe SGLT2-e13 lies in a region of overlap with another SGLT2-unrelated transcript, and thus is less specific to the SGLT2 sequence compared with other SGLT2 primer/probes we tested. The potential consequences of using this probe are further discussed in "the SGLT2 locus" section below. In summary, these data suggest that the steady state levels of SGLT2 transcripts are highly specific for the cortex of the kidney in humans.
SGLT5, a relatively uncharacterized SGLT family member, is also found to have a highly kidney-abundant tissue expression pattern.
The expression of SGLT5 in a subset of the 72 human tissues is shown in Figure 2A tissues, we replotted the data without the kidney cortex and medulla data in Figure 2B . Unlike the profile observed for SGLT2, which has little or no detectable level in tissues other than the kidney cortex and medulla, SGLT5 exhibits a low level of expression in some tissues like the kidney pelvis, vas deferens, left atrium of the heart, skin, and testes. However, the expression of SGLT5 in the kidney cortex is still 35 times higher than that observed in the vas deferens.
These data suggest that the expression of SGLT5 in human tissues is highly abundant in kidney, compared with other tissues.
The Small Intestine and Muscle-Abundant
As shown in Figure 3A , the expression of SGLT1 (SLC5A1), the closest homolog to SGLT2, is essentially restricted to the small intestine, the skeletal muscle, and the heart (the data for all 72 human tissues are in the Appendix, Additional Figure S7 and Additional Table S2 ).
Minor numbers of transcripts are observed in the trachea, prostate, cervix, and mesenteric adipose tissue, but like SGLT2, we see no evidence for any expression in the brain subregions tested.
The GAPDH data indicates successful first strand synthesis and PCR in all samples. The expression pattern of SGLT1 across human tissues we observed above is generally consistent with reports from other studies using mRNAbased methods. 6, 7, 9 It is worth noting that brain expression of SGLT1 has been reported in other species (rats and pigs) using immunological, in situ hybridization and RT-PCR techniques. 29, 32, 33 Interestingly, the glucose sensor SAAT1 
The SGLT2 Locus
The discrepancy between our results and that indicates that expressed sequence tags (ESTs)
for C16orf58 versus that of SGLT2 can be found in the NBCI database at the relative abundance of 10 transcripts to one (data not shown). We designed a primer/probe set located in exon 8 of C16orf58 and one that is specific for C16orf58
( Figure 6B ). Expression profiling analysis with this primer/probe set indicates that this gene is expressed ubiquitously with the highest steady state RNA levels also located in the cortex of the kidney, the cerebellum ( Figure 6C ), and the The data presented clearly demonstrates that SGLT2 is expressed primarily in the cortex of the kidney at steady state levels that are several hundred-fold greater than the tissue with the next highest abundance, the kidney medulla.
We have confirmed these data with multiple primer/probe combinations representing essentially the entire SGLT2 locus.
These data are in agreement with some previous studies 9, 16, 20 Additional Table S2 . Expression of sodium glucose cotransporter proteins SGLT1 and SGLT2 in selected human tissues.
The numbers of SGLT1 and SGLT2 molecules per µg of RNA in selected human tissues are shown in the table. SGLT2-e1,2: amplicon spans exon 1 and 2 of the SGLT2 gene; SGLT2-e4,5: amplicon spans exon 4 and 5 of the SGLT2 gene; SGLT2-e6,7: amplicon spans exon 6 and 7 of the SGLT2 gene; SGLT2-e9,10: amplicon spans exon 9 and 10 of the SGLT2 gene; SGLT2-e13: amplicon is located in exon 13 of the SGLT2 gene.
Additional Figure S1 . Expression of sodium glucose cotransporter protein SGLT2 in human tissues measured by primer/probe set on exons 6-7. Copies of SGLT2 transcript per 1 µg of total RNA are shown on the top X-axis of the graph. Log2 value of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) transcript per 1 µg of total RNA is shown on the bottom X-axis. All 72 human tissues are shown on the Y-axis. The average number of transcripts from tissues of three human donors is shown in each tissue category. The error bar represents the standard deviation of transcripts of the three donors. SGLT2 tissue expression from TaqMan quantitative polymerase chain reactions (PCR) performed using primer/ probe set designed in exon 6-7 of SGLT2 (SGLT2-e6,7).
Additional Figure S2 . Expression of sodium glucose cotransporter protein SGLT2 in human tissues measured by primer/probe set on exons 1-2. Copies of SGLT2 transcript per 1 µg of total RNA are shown on the top X-axis of the graph. Log2 value of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) transcript per 1 µg of total RNA is shown on the bottom X-axis. All 72 human tissues are shown on the Y-axis. The average number of transcripts from tissues of three human donors is shown in each tissue category. The error bar represents the standard deviation of transcripts of the three donors. SGLT2 tissue expression from TaqMan quantitative polymerase chain reactions (PCR) performed using primer/ probe set designed in exon 1-2 of SGLT2 (SGLT2-e1,2).
Additional Figure S3 . Expression of sodium glucose cotransporter protein SGLT2 in human tissues measured by primer/probe set on exons 4-5. Copies of SGLT2 transcript per 1 µg of total RNA are shown on the top X-axis of the graph. Log2 value of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) transcript per 1 µg of total RNA is shown on the bottom X-axis. All 72 human tissues are shown on the Y-axis. The average number of transcripts from tissues of three human donors is shown in each tissue category. The error bar represents the standard deviation of transcripts of the three donors. SGLT2 tissue expression from TaqMan quantitative polymerase chain reactions (PCR) performed using primer/ probe set designed in exon 4-5 of SGLT2 (SGLT2-e4,5).
Additional Figure S4 . Expression of sodium glucose cotransporter protein SGLT2 in human tissues measured by primer/probe set on exons 9-10. Copies of SGLT2 transcript per 1 µg of total RNA are shown on the top X-axis of the graph. Log2 value of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) transcript per 1 µg of total RNA is shown on the bottom X-axis. All 72 human tissues are shown on the Y-axis. The average number of transcripts from tissues of three human donors is shown in each tissue category. The error bar represents the standard deviation of transcripts of the three donors. SGLT2 tissue expression from TaqMan quantitative polymerase chain reactions (PCR) performed using primer/ probe set designed in exon 9-10 of SGLT2 (SGLT2-e9,10).
Additional Figure S5 . Expression of sodium glucose cotransporter protein SGLT2 in human tissues measured by primer/probe set on exons 13. Copies of SGLT2 transcript per 1 µg of total RNA are shown on the top X-axis of the graph. Log2 value of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) transcript per 1 µg of total RNA is shown on the bottom X-axis. All 72 human tissues are shown on the Y-axis. The average number of transcripts from tissues of three human donors is shown in each tissue category. The error bar represents the standard deviation of transcripts of the three donors. SGLT2 tissue expression from TaqMan quantitative polymerase chain reactions (PCR) performed using primer/ probe set designed in exon 13 of SGLT2 (SGLT2-e13).
Additional Figure S6 . Expression of sodium glucose cotransporter protein SGLT5 in human tissues. Copies of SGLT5 transcript per 1 µg of total RNA are shown on the top X-axis of the graph. Log2 value of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) transcript per 1 µg of total RNA is shown on the bottom X-axis. All 72 human tissues are shown on the Y-axis. The average number of transcripts from tissues of three human donors is shown in each tissue category. The error bar represents the standard deviation of transcripts of the three donors.
Additional Figure S7 . Expression of sodium glucose cotransporter protein SGLT1 in human tissues. Copies of SGLT transcript per 1 µg of total RNA are shown on the top X-axis of the graph. Log2 value of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) transcript per 1 µg of total RNA is shown on the bottom X-axis. All 72 human tissues are shown on the Y-axis. The average number of transcripts from tissues of three human donors is shown in each tissue category. The error bar represents the standard deviation of transcripts of the three donors. SGLT1 tissue expression from TaqMan quantitative polymerase chain reactions (PCR) performed using primer/ probe set designed in exon 4-5 of SGLT1.
Additional Figure S8 . Expression of sodiumdependent amino acid transporter (SAAT1) in human tissues. Copies of sodium glucose cotransporter protein (SGLT) transcript per 1 µg of total RNA are shown on the top X-axis of the graph. Log2 value of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) transcript per 1 µg of total RNA is shown on the bottom X-axis. All 72 human tissues are shown on the Y-axis. The average number of transcripts from tissues of three human donors is shown in each tissue category. The error bar represents the standard deviation of transcripts of the three donors. SAAT1 tissue expression from TaqMan quantitative polymerase chain reactions (PCR) performed using primer/ probe set designed in exon 2-3 of SAAT1.
Additional Figure S9 . Expression of sodium glucose cotransporter (SGLT4) in human tissues. Copies of SGLT transcript per 1 µg of total RNA are shown on the top X-axis of the graph. Log2 value of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) transcript per 1 µg of total RNA is shown on the bottom X-axis. All 72 human tissues are shown on the Y-axis. The average number of transcripts from tissues of three human donors is shown in each tissue category. The error bar represents the standard deviation of transcripts of the three donors. SGLT4 tissue expression from TaqMan quantitative polymerase chain reactions (PCR) performed using primer/probe set designed in exon 11 of SGLT4.
Additional Figure S10 . Expression of sodium glucose cotransporter protein SGLT6 in human tissues. Copies of SGLT6 transcript per 1 µg of total RNA are shown on the top X-axis of the graph. Log2 value of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) transcript per 1 µg of total RNA is shown on the bottom X-axis. All 72 human tissues are shown on the Y-axis. The average number of transcripts from tissues of three human donors is shown in each tissue category. The error bar represents the standard deviation of transcripts of the three donors.
Additional Figure S13 . 
